Loading insider details...
Latest Form 4 (Jun 11, 2026): Exercise/Conversion of 1,429 AXSM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 1,429 | n/a |
| Jun 9, 2026 | Axsome Therapeutics, Inc. (AXSM) | Grant/Award | 1,721 | n/a |
| Jun 2, 2026 | Axsome Therapeutics, Inc. (AXSM) | Sale | 6,000 | $1.40M |
| Feb 28, 2026 | Axsome Therapeutics, Inc. (AXSM) | Sale | 25,000 | $4.03M |
| Feb 26, 2026 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 6,250 | $30.9K |
| Feb 24, 2026 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 12,485 | $61.8K |
| Feb 11, 2026 | Axsome Therapeutics, Inc. (AXSM) | Exercise/Conversion | 5,193 | $41.6K |
| Sep 9, 2025 | Axsome Therapeutics, Inc. (AXSM) | Purchase | 800 | $101.8K |
| Jun 10, 2025 | Axsome Therapeutics, Inc. (AXSM) | Grant/Award | 3,166 | n/a |
| May 29, 2025 | Axsome Therapeutics, Inc. (AXSM) | Sale | 3,750 | $395.5K |